98
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Participation in highly subsidised cervical cancer screening by women in Enugu, South-east Nigeria

, , &
Pages 305-307 | Published online: 02 Jul 2009
 

Summary

The current study was designed to evaluate the level of participation in a highly subsidised cervical screening in a resource-poor country. A total of 989 cervical smears performed on 932 women in Enugu, south-east Nigeria, over a 10-year period (January 1995 – December 2004) was reviewed. The level of participation in cervical screening was very low, as <1% of the targeted women population participated. Almost 68% of the participants were referred for the screening and the majority (52.3%) were from lower social classes because the programme was highly subsidised. A total of 646 (65.3%) smears were normal. Of the abnormal smears, 193 (19.5%) had non-specific inflammatory changes, 136 (13.8%) showed dyskaryotic cells while 14 (1.4%) had neoplastic changes. A total of 57 (6.1%) women had more than one cervical cancer screening and they were characterised by increasing age, up to 59 years, higher social classes and contraceptive users in lower social classes. To reverse the low level of participation in cervical cancer screening in developing countries, there is a need to provide highly subsidised (if not free) cervical cancer screening services, which must be followed by sustained cervical cancer awareness campaign.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.